Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma.
Eur J Endocrinol. 2022 Apr 29;186(6):631-643. doi: 10.1530/EJE-21-1259.
Eur J Endocrinol. 2022.
PMID: 35333737
Free PMC article.